Synopsis
Enteroviruses are small, contagious single-stranded ribonucleic acid (RNA) viruses associated with several human and mammalian diseases. The enterovirus genus comprise 12 species which includes four major serotypes including poliovirus, coxsackievirus, echovirus and enterovirus. The newly identified enteroviruses are named with a system of consecutive numbers as EV68, EV69, EV70, etc. Enteroviruses are among the most common human viruses, infecting approximately one billion people annually, majorly infants and children. Diseases such as polio, meningitis, pancreatitis, hepatitis, encephalitis, hand, foot and mouth disease; birth defects, attention deficit hyperactivity disorder and cardiac disorders are caused by different types of enteroviruses.
The global Enterovirus Diagnostic market size is expected to reach US$ 983.5 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Enterovirus Diagnostic in various end use industries. The expanding demands from the Hospitals, Laboratories and Others,, are propelling Enterovirus Diagnostic market. Viral Isolation Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Serology Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enterovirus Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enterovirus Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enterovirus Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enterovirus Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enterovirus Diagnostic covered in this report include Merck Millipore, Quidel Corporation, Norgen Biotek, Quest Diagnostics, BioMerieux, Cepheid, Thermo Fisher Scientific and Abbott Laboratories, etc.
The global Enterovirus Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Millipore
Quidel Corporation
Norgen Biotek
Quest Diagnostics
BioMerieux
Cepheid
Thermo Fisher Scientific
Abbott Laboratories
Global Enterovirus Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enterovirus Diagnostic market, Segment by Type:
Viral Isolation Testing
Serology Testing
Polymerase Chain Reaction (PCR) Assay
Global Enterovirus Diagnostic market, by Application
Hospitals
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Enterovirus Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Enterovirus Diagnostic
1.1 Enterovirus Diagnostic Market Overview
1.1.1 Enterovirus Diagnostic Product Scope
1.1.2 Enterovirus Diagnostic Market Status and Outlook
1.2 Global Enterovirus Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Enterovirus Diagnostic Market Size by Region (2018-2029)
1.4 Global Enterovirus Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global Enterovirus Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Enterovirus Diagnostic Market Size (2018-2029)
1.6.1 North America Enterovirus Diagnostic Market Size (2018-2029)
1.6.2 Europe Enterovirus Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific Enterovirus Diagnostic Market Size (2018-2029)
1.6.4 Latin America Enterovirus Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa Enterovirus Diagnostic Market Size (2018-2029)
2 Enterovirus Diagnostic Market by Type
2.1 Introduction
2.1.1 Viral Isolation Testing
2.1.2 Serology Testing
2.1.3 Polymerase Chain Reaction (PCR) Assay
2.2 Global Enterovirus Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Enterovirus Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global Enterovirus Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Enterovirus Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Enterovirus Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Enterovirus Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Enterovirus Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Enterovirus Diagnostic Revenue Breakdown by Type (2018-2029)
3 Enterovirus Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Laboratories
3.1.3 Others
3.2 Global Enterovirus Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Enterovirus Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global Enterovirus Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Enterovirus Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Enterovirus Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Enterovirus Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Enterovirus Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Enterovirus Diagnostic Revenue Breakdown by Application (2018-2029)
4 Enterovirus Diagnostic Competition Analysis by Players
4.1 Global Enterovirus Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enterovirus Diagnostic as of 2022)
4.3 Date of Key Players Enter into Enterovirus Diagnostic Market
4.4 Global Top Players Enterovirus Diagnostic Headquarters and Area Served
4.5 Key Players Enterovirus Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 Enterovirus Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck Millipore
5.1.1 Merck Millipore Profile
5.1.2 Merck Millipore Main Business
5.1.3 Merck Millipore Enterovirus Diagnostic Products, Services and Solutions
5.1.4 Merck Millipore Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Millipore Recent Developments
5.2 Quidel Corporation
5.2.1 Quidel Corporation Profile
5.2.2 Quidel Corporation Main Business
5.2.3 Quidel Corporation Enterovirus Diagnostic Products, Services and Solutions
5.2.4 Quidel Corporation Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 Quidel Corporation Recent Developments
5.3 Norgen Biotek
5.3.1 Norgen Biotek Profile
5.3.2 Norgen Biotek Main Business
5.3.3 Norgen Biotek Enterovirus Diagnostic Products, Services and Solutions
5.3.4 Norgen Biotek Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Enterovirus Diagnostic Products, Services and Solutions
5.4.4 Quest Diagnostics Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 BioMerieux
5.5.1 BioMerieux Profile
5.5.2 BioMerieux Main Business
5.5.3 BioMerieux Enterovirus Diagnostic Products, Services and Solutions
5.5.4 BioMerieux Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 BioMerieux Recent Developments
5.6 Cepheid
5.6.1 Cepheid Profile
5.6.2 Cepheid Main Business
5.6.3 Cepheid Enterovirus Diagnostic Products, Services and Solutions
5.6.4 Cepheid Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 Cepheid Recent Developments
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Profile
5.7.2 Thermo Fisher Scientific Main Business
5.7.3 Thermo Fisher Scientific Enterovirus Diagnostic Products, Services and Solutions
5.7.4 Thermo Fisher Scientific Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Scientific Recent Developments
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Profile
5.8.2 Abbott Laboratories Main Business
5.8.3 Abbott Laboratories Enterovirus Diagnostic Products, Services and Solutions
5.8.4 Abbott Laboratories Enterovirus Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Laboratories Recent Developments
6 North America
6.1 North America Enterovirus Diagnostic Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Enterovirus Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Enterovirus Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Enterovirus Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Enterovirus Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Enterovirus Diagnostic Market Dynamics
11.1 Enterovirus Diagnostic Industry Trends
11.2 Enterovirus Diagnostic Market Drivers
11.3 Enterovirus Diagnostic Market Challenges
11.4 Enterovirus Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List